Correlation Between AN2 Therapeutics and Monte Rosa

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Monte Rosa Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Monte Rosa.

Diversification Opportunities for AN2 Therapeutics and Monte Rosa

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between AN2 and Monte is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Monte Rosa go up and down completely randomly.

Pair Corralation between AN2 Therapeutics and Monte Rosa

Given the investment horizon of 90 days AN2 Therapeutics is expected to generate 1.16 times more return on investment than Monte Rosa. However, AN2 Therapeutics is 1.16 times more volatile than Monte Rosa Therapeutics. It trades about 0.19 of its potential returns per unit of risk. Monte Rosa Therapeutics is currently generating about -0.08 per unit of risk. If you would invest  110.00  in AN2 Therapeutics on August 27, 2024 and sell it today you would earn a total of  24.00  from holding AN2 Therapeutics or generate 21.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

AN2 Therapeutics  vs.  Monte Rosa Therapeutics

 Performance 
       Timeline  
AN2 Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in AN2 Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, AN2 Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Monte Rosa Therapeutics 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Monte Rosa Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Monte Rosa exhibited solid returns over the last few months and may actually be approaching a breakup point.

AN2 Therapeutics and Monte Rosa Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AN2 Therapeutics and Monte Rosa

The main advantage of trading using opposite AN2 Therapeutics and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.
The idea behind AN2 Therapeutics and Monte Rosa Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.